Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and similar GLP-1 receptor agonists have transformed weight loss treatment for millions, yet clinical trials show response rates ranging from 35% to 75% depending on the population studied. Not everyone experiences the same weight loss trajectory, and understanding why is critical to achieving your health goals. PlexusDx uses genetic insight and precision dosing to match you with the right medication and dose from the start.

Why GLP-1 Medications Don't Work the Same for Everyone

Your genes influence how your body produces and responds to hunger hormones, appetite regulation proteins, and metabolic pathways. Variations in genes like GLP1R and GIPR determine how efficiently your body recognizes and acts on GLP-1 therapy signals. Someone with a highly responsive GLP1R variant may achieve significant weight loss at lower doses, while another person with a different genetic profile might require higher doses or see more modest initial results.

Beyond genetics, factors like baseline weight, insulin resistance, gut health, activity level, and medication adherence all shape real-world outcomes. A person with severe insulin resistance may need additional metabolic support alongside semaglutide to optimize results. Age, sex, and prior weight loss attempts also influence how quickly and dramatically your body responds to GLP-1 therapy over time.

Genetic Variants That Predict GLP-1 Treatment Response

PlexusDx Precision Peptide Genetic Test analyzes key variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 to map your peptide-pathway profile across 14 distinct biological pathways and 49 peptides. These variants don't determine whether you'll lose weight—they reveal which metabolic levers your body is most responsive to adjusting. Someone carrying the T-allele variant of GLP1R may show faster appetite suppression, while FTO rs9939609 variants relate to baseline hunger signaling and fat storage patterns.

Mapping 150+ genetic insights helps PlexusDx clinicians predict which compound—semaglutide, tirzepatide, or a dual protocol—and which starting dose aligns with your biology. This personalized approach reduces trial-and-error and accelerates progress toward your weight loss goal.

Real-World Response Rates: What the Evidence Shows

Clinical trials of semaglutide show that approximately 50-70% of participants achieve at least 10% body weight loss, with higher responders reaching 15-22% reductions over 68 weeks. However, trial populations are typically highly motivated, closely monitored, and relatively homogeneous in age and metabolic profile. Real-world data from actual clinical practice reveals greater diversity in outcomes, with some individuals seeing transformative results within weeks and others requiring several months of gradual dose escalation.

Tirzepatide, a dual GIP/GLP-1 agonist, shows numerically higher response rates in trials—approximately 85% achieve 5% or greater weight loss—partly because it targets two appetite pathways instead of one. PlexusDx offers both compounds and a GLP-Squared dual protocol option, allowing clinicians to select based on your genetic profile and response trajectory. The key insight: personalization, not the medication alone, drives success rates above 80% in precision-matched patients.

How PlexusDx Personalizes Your GLP-1 Protocol for Maximum Success

PlexusDx starts by understanding your baseline: family history, current weight and metabolism, prior weight loss attempts, lifestyle capacity, and genetic predisposition via the optional Precision Peptide Genetic Test ($99 add-on after your first month). Clinicians then select your compound—semaglutide injection (from $149/mo), oral semaglutide, tirzepatide injection (from $249/mo), oral tirzepatide, or the GLP-Squared dual protocol—based on your peptide-pathway profile. Your dose may need to go up as your body adapts. Your price won't, because PlexusDx pricing is flat per-compound across all commitment tiers, not dose-based.

Throughout treatment, PlexusDx tracks your weekly weight, appetite changes, energy levels, and side effects to fine-tune your protocol. If response plateaus, genetic data guides whether you'd benefit from switching compounds, adding a complementary peptide, or optimizing lifestyle factors like protein intake and exercise timing. All medications ship from licensed 503A compounding pharmacies, require no insurance, carry no membership fees, and are HSA/FSA eligible—making precision care accessible and affordable across all 50 states.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What percentage of people lose weight on semaglutide or GLP-1 therapy?

Clinical trials show 50-70% of semaglutide users achieve at least 10% body weight loss, with higher responders reaching 15-22% reductions. Tirzepatide shows numerically higher rates around 85% achieving 5% or greater loss. Real-world success depends heavily on genetic fit, dose optimization, and adherence—which is why PlexusDx uses genetic testing and precision dosing to boost outcomes.

Can genetic testing predict if GLP-1 will work for me?

The PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R—plus 150+ additional insights across 14 metabolic pathways—to predict your individual response pattern and which compound and starting dose align best with your biology. Genetic data doesn't guarantee outcome, but it dramatically improves the odds of selecting an effective protocol on the first try.

How much does personalized GLP-1 therapy cost at PlexusDx?

Compounded semaglutide injection starts at $149/mo flat; tirzepatide injection starts at $249/mo flat. Oral options and dual protocols are also available. Your dose may need to go up. Your price won't. All medications are HSA/FSA eligible, no insurance required, and available in all 50 states without membership fees.

What if GLP-1 doesn't work as well as expected for me?

PlexusDx clinicians monitor your progress weekly and adjust your protocol based on real data. If response is slower or plateaus, your genetic profile guides whether switching to tirzepatide, adding a complementary compound via GLP-Squared, or optimizing dosing and lifestyle factors will accelerate results. Personalization reduces the need for guesswork.

How do genetic variants like GLP1R rs6923761 affect my weight loss?

Variants in GLP1R influence how sensitively your cells recognize GLP-1 signals, affecting appetite suppression speed and intensity. Someone with a highly responsive variant may see faster results at lower doses; others may need gradual escalation. The PlexusDx Precision Peptide Genetic Test maps your exact pathway profile so clinicians can predict and optimize your individual response trajectory from day one.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves